Dexco 미래 성장

BOVESPA:DXCO3 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (BRL Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	9,001	687	990	1,187	7
12/31/2025	8,459	669	809	1,095	9
12/31/2024	8,110	253	138	776	2
9/30/2024	8,119	337	86	1,482	N/A
6/30/2024	7,649	542	-6	1,440	N/A
3/31/2024	7,607	602	39	1,352	N/A
12/31/2023	7,383	790	98	1,346	N/A
9/30/2023	7,415	812	-153	975	N/A
6/30/2023	7,808	668	-151	993	N/A
3/31/2023	8,068	680	-456	726	N/A
12/31/2022	8,487	756	-419	794	N/A
9/30/2022	8,757	1,128	15	1,226	N/A
6/30/2022	8,773	1,229	142	1,227	N/A
3/31/2022	8,533	1,776	550	1,505	N/A
12/31/2021	8,170	1,725	851	1,708	N/A
9/30/2021	7,813	1,446	863	1,585	N/A
6/30/2021	7,414	1,315	1,326	1,930	N/A
3/31/2021	6,486	574	1,289	1,813	N/A
12/31/2020	5,880	454	1,020	1,508	N/A
9/30/2020	5,472	437	1,089	1,536	N/A
6/30/2020	5,003	341	740	1,187	N/A
3/31/2020	5,101	434	578	1,050	N/A
12/31/2019	5,012	406	653	1,108	N/A
9/30/2019	4,789	-21	273	744	N/A
6/30/2019	4,993	327	-22	445	N/A
3/31/2019	5,016	425	-4	437	N/A
12/31/2018	4,949	432	-59	383	N/A
9/30/2018	4,789	658	-85	303	N/A
6/30/2018	4,296	365	N/A	356	N/A
3/31/2018	4,045	223	N/A	340	N/A
12/31/2017	3,991	185	N/A	405	N/A
9/30/2017	3,917	125	N/A	470	N/A
6/30/2017	3,864	72	N/A	346	N/A
3/31/2017	3,960	47	N/A	540	N/A
12/31/2016	3,910	24	N/A	451	N/A
9/30/2016	3,836	50	N/A	400	N/A
6/30/2016	3,911	48	N/A	493	N/A
3/31/2016	3,863	85	N/A	443	N/A
12/31/2015	3,963	183	N/A	574	N/A
9/30/2015	4,048	221	N/A	691	N/A
6/30/2015	4,064	275	N/A	837	N/A
3/31/2015	4,056	296	N/A	739	N/A
12/31/2014	3,985	390	N/A	678	N/A
9/30/2014	3,953	366	N/A	685	N/A
6/30/2014	3,923	450	N/A	626	N/A
3/31/2014	3,937	526	N/A	709	N/A
12/31/2013	3,873	534	N/A	768	N/A

애널리스트 미래 성장 예측

수입 대 저축률: DXCO3 의 연간 예상 수익 증가율( 32.4% )이 saving rate( 10.4% 보다 높습니다. ).

수익 vs 시장: DXCO3 의 연간 수익( 32.4% ) BR 시장( 12.5% 보다 빠르게 성장할 것으로 예상됩니다. 12.5% 연간).

고성장 수익: DXCO3 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: DXCO3 의 수익(연간 4.6% ) BR 시장( 7.4% 보다 느리게 성장할 것으로 예상됩니다. 7.4% 연간).

고성장 수익: DXCO3 의 수익(연간 4.6% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: DXCO3 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 9 %).

Dexco 미래 성장

Future 기준 확인 3/6

주요 정보

최근 미래 성장 업데이트

Consensus EPS estimates fall by 14%

Consensus EPS estimates fall by 16%

Analysts Are Updating Their Dexco S.A. (BVMF:DXCO3) Estimates After Its Second-Quarter Results

Consensus EPS estimates increase by 13%

Consensus EPS estimates increase by 13%

Consensus EPS estimates increase by 13%

Recent updates

New minor risk - Profit margin trend

Third quarter 2024 earnings: Revenues exceed analyst expectations

Is Dexco (BVMF:DXCO3) A Risky Investment?

Consensus EPS estimates fall by 14%

Dexco S.A.(BOVESPA:DXCO3) dropped from FTSE All-World Index (USD)

Consensus EPS estimates fall by 16%

Analysts Are Updating Their Dexco S.A. (BVMF:DXCO3) Estimates After Its Second-Quarter Results

Second quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching

Returns On Capital At Dexco (BVMF:DXCO3) Have Stalled

Consensus EPS estimates increase by 13%

Consensus EPS estimates increase by 13%

Consensus EPS estimates increase by 13%

Consensus EPS estimates increase by 13%

Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 26%

Is It Time To Consider Buying Dexco S.A. (BVMF:DXCO3)?

Consensus EPS estimates fall by 37%, revenue upgraded

Slowing Rates Of Return At Dexco (BVMF:DXCO3) Leave Little Room For Excitement

Dexco's (BVMF:DXCO3) Earnings Might Not Be As Promising As They Seem

Consensus EPS estimates increase by 19%, revenue downgraded

New minor risk - Earnings quality

New minor risk - Share price stability

Full year 2023 earnings: EPS exceeds analyst expectations

Now 25% overvalued after recent price rise

Dexco S.A. to Report Q4, 2023 Results on Mar 06, 2024

Dexco S.A.'s (BVMF:DXCO3) Earnings Are Not Doing Enough For Some Investors

Dexco S.A., Annual General Meeting, Apr 26, 2024

Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet

At R$7.43, Is Dexco S.A. (BVMF:DXCO3) Worth Looking At Closely?

Consensus EPS estimates increase by 12%, revenue downgraded

Consensus EPS estimates increase by 45%, revenue downgraded

Price target decreased by 8.5% to R$9.82

Returns Are Gaining Momentum At Dexco (BVMF:DXCO3)

Is Dexco (BVMF:DXCO3) A Risky Investment?

Second quarter 2023 earnings released

Consensus EPS estimates increase by 19%

Consensus EPS estimates increase by 22%

Returns At Dexco (BVMF:DXCO3) Are On The Way Up

Consensus EPS estimates increase by 10%

Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?

Consensus EPS estimates fall by 13%

Investor sentiment improves as stock rises 24%

First quarter 2023 earnings released: EPS: R$0.18 (vs R$0.27 in 1Q 2022)

Consensus EPS estimates increase by 12%, revenue downgraded

Consensus EPS estimates increase by 15%

Investor sentiment deteriorates as stock falls 16%

Consensus EPS estimates fall by 24%

Price target decreased by 10% to R$10.91

We Like These Underlying Return On Capital Trends At Dexco (BVMF:DXCO3)

Price target decreased by 10.0% to R$12.65

We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt

Dexco (BVMF:DXCO3) Might Have The Makings Of A Multi-Bagger

Price target decreased to R$15.76

Less than half of directors are independent

We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt

Investor sentiment improved over the past week

Third quarter 2022 earnings: Revenues miss analyst expectations

Consensus EPS estimates increase by 28%

Is Now The Time To Look At Buying Dexco S.A. (BVMF:DXCO3)?

Investors Will Want Dexco's (BVMF:DXCO3) Growth In ROCE To Persist

We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt

Consensus EPS estimates fall by 10%

Second quarter 2022 earnings released

Is There Now An Opportunity In Dexco S.A. (BVMF:DXCO3)?

First quarter 2022 earnings: Revenues exceed analyst expectations

There's Been No Shortage Of Growth Recently For Dexco's (BVMF:DXCO3) Returns On Capital

Consensus forecasts updated